Organization
|
Name and Title
|
---|
National Cancer Institute Office of Cancer Centers
|
Henry P. Ciolino, PhD
Acting Director
Office of Cancer Centers
National Cancer Institute
|
Biomedical Advanced Research and Development Authority (BARDA)
|
Marcy Grace, PhD
Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
Biomedical Advanced Research and Development Authority
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services
|
National Science Foundation (NSF) SBIR Program
|
Jesus Soriano, MD, PhD, MBA
Program Director, SBIR/STTR, National Science Foundation
|
Department of Defense Congressionally Directed Medical Research Programs (DoD CDRMP)
|
Donna M. Kimbark, Ph.D.
Program Manager
Congressionally Directed Medical Research Programs
|
Shui-Lin (Stan) Niu, Ph.D.
Science Officer
ARP/BMFRP/PRCRP/SBIR
Congressionally Directed Medical Research Programs
|
National Center for Advancing Translational Sciences (NCATS)
|
Lili M. Portilla, MPA
Director, Office of Strategic Alliances
National Center for Advancing Translational Sciences (NCATS), NIH
|
Nora Yang, PhD
Senior Scientist, Therapeutics for Rare and Neglected Diseases
Director, Portfolio Management and Strategic Operations
Division of Pre-Clinical Innovation
National Center for Advancing Translational Sciences (NCATS), NIH
|
Krishna “Balki” Balakrishnan, Ph.D., M.B.A.
Senior Technology Transfer Manager
Office of Strategic Alliances
Office of Policy, Communications and Strategic Alliances
Office of the Director
National Center for Advancing Translational Sciences (NCATS), NIH
|
NCI Experimental Therapeutics (NExT)
|
Michael J. Difilippantonio, Ph.D.
Program Manager for Therapeutic and Diagnostic Initiatives
Office of the Director, Division of Cancer Treatment & Diagnosis (DCTD)
National Cancer Institute/NIH
|
Weiwei Chen, PhD
Program Manager
NCI Experimental Therapeutics (NExT) Program
National Cancer Institute/NIH
|
NCI PREVENT Cancer Preclinical Drug Development Program (PREVENT)
|
Shizuko Sei, M.D.
Medical Officer & Program Director
Chemopreventive Agent Development Research Group
Division of Cancer Prevention, NCI, NIH
|
Elizabeth Glaze, PhD, DABT
Program Director
Chemopreventive Agent Development Research Group
Division of Cancer Prevention
National Cancer Institute
|
NCI Frederick National Laboratory for Cancer Research & RAS initiative
|
Nguyen K. Nguyen, PhD, PMP
Partnership Alliance Manager
Partnership Development Office (PDO)
Frederick National Laboratory for Cancer Research
|
Andrew Quong, Ph.D.
Director, Partnership Development Office (PDO)
Frederick National Laboratory for Cancer Research
|
NCI Frederick National Laboratory for Cancer Research
Center for Advanced Preclinical Research
|
Sergei Kozlov, PhD, MBA, PMP
Principal Scientist/Team Leader
Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)
|
Zoë Weaver Ohler, PhD
Principal Scientist, Preclinical Evaluation Team Leader
Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)
|
NCI Patient-Derived Xenograft (PDX) Repository
|
Yvonne A. Evrard, Ph.D. [Contractor]
Operations Manager
NCI Patient-Derived Models Repository, Support for DCTD
Frederick National Laboratory for Cancer Research
|
FDA Center for Drug Evaluation and Research (CDER)
|
Shawna Weis, PhD
Pharmacologist, Office of Hematology and Oncology Products, CDER, FDA
|
Haw-Jyh (Brian) Chiu, PhD
Toxicologist, Division of Hematology Oncology Toxicology
Center for Drug Evaluation and Research/FDA
|
Tiffany K. Ricks, PhD
Pharmacologist, Division of Hematology Oncology Toxicology
Office of Hematology and Oncology Products
Center for Drug Evaluation and Research/FDA
|
Lee Pai-Scherf, MD
Medical Officer, Office of Oncology Drug Products
Center for Drug Evaluation and Research/FDA
|
FDA Center for Devices and Radiological Health (CDRH)
|
Aaron Schetter, PhD, MPH
Scientific Reviewer
Division of Molecular Genetics and Pathology/OIR
FDA Center for Devices and Radiological Health
|
Parexel
|
Reem Elbekai, BPharm, PhD, DABT
Senior Consultant, PAREXEL International
|
Barry S. Sall, RAC, FRAPS
Principal Consultant
PAREXEL Consulting
|
Ted Carver, Ph.D.
Principal Consultant
PAREXEL International
|
Generic Devices Consulting
|
John Greenbaum, BS, MBA
President
Generic Devices Consulting, Inc
|
Indiana Bio
|
Kristin M. Jones
President and CEO
Indiana Health Industry Forum
|
J&J Innovation (JLabs)
|
Samantha Lifson
J&J Innovation (JLabs)
|
BioHealth Innovation
|
Ethan Byler
Managing Director
BioHealth Innovation, Inc.
|
NCI Biospecimen Resources
|
Lokesh Agrawal, Ph.D.
Program Director
Biorepositories and Biospecimen Research Branch (BBRB)
Cancer Diagnosis Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
|
Life Science Nation
|
Dennis Ford
Founder & CEO
Life Science Nation
|
Danielle Silva
VP of Business Development
Life Science Nation
|
Office of Grants Administration
|
Shane Woodward
Branch Chief, Division of Cancer Treatment and Diagnosis
Office of Grants Administration, NCI
|
NCI SRO
|
Nadeem Khan, Ph.D.
Scientific Review Officer
Technology Contract Review
Division of Extramural Activities, NCI/NIH
|
CSR SRO
|
Syed M. Quadri, PH.D.
Chief, Oncology Translational Clinical IRG
Center for Scientific Review, NIH
|
Office of Acquisition
|
Donna Perry-Lalley, MS, MSM
Contracting Officer, Acting Branch Chief
Prevention, Control and Population Sciences Branch
Office of Acquisitions, NCI
|
Centers for Medicare & Medicaid Services
|
Marc Harstein
Director
Hospital and Ambulatory Policy Group
Center for Medicare
Centers for Medicare and Medicaid Services
|
IGI Tech
|
William Plishker, PhD
Co-Founder and CEO
IGI Technologies
|
ImaginAb
|
Jennifer S. Keppler
Chief Operating Officer
ImaginAb
|